Thalidomide–A Notorious Sedative to a Wonder Anticancer Drug

Author(s): Shuang Zhou, Fengfei Wang, Tze-Chen Hsieh, Joseph M. Wu, Erxi Wu

Journal Name: Current Medicinal Chemistry

Volume 20 , Issue 33 , 2013

Become EABM
Become Reviewer
Call for Editor


In the past 50 years, thalidomide has undergone a remarkable metamorphosis from a notorious drug inducing birth defects into a highly effective therapy for treating leprosy and multiple myeloma. Today, most notably, thalidomide and its analogs have shown efficacy against a wide variety of diseases, including inflammation and cancer. The mechanism underlying its teratogenicity as well as its anticancer activities has been intensively studied. This review summarizes the biological effects and therapeutic uses of thalidomide and its analogs, and the underlying mechanisms of thalidomide’s action with a focus on its suppression of tumor growth.

Keywords: Thalidomide, teratogenesis, angiogenesis, cancer, multiple myeloma.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 19 September, 2013
Page: [4102 - 4108]
Pages: 7
DOI: 10.2174/09298673113209990198
Price: $65

Article Metrics

PDF: 29